AD 01
This FKBPL-derived peptide targets CD44, upregulating its expression to inhibit breast cancer stem cell growth and promote differentiation. It also suppresses angiogenesis by blocking endothelial cell migration and tubule formation, demonstrating anti-tumor efficacy in both in vitro assays and in vivo xenograft models.
Product Specifications
Molecular Weight
2703.94
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog